These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 1449531)

  • 1. Potentiation of CB 1954 cytotoxicity by reduced pyridine nucleotides in human tumour cells by stimulation of DT diaphorase activity.
    Friedlos F; Biggs PJ; Abrahamson JA; Knox RJ
    Biochem Pharmacol; 1992 Nov; 44(9):1739-43. PubMed ID: 1449531
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bioactivation of 5-(aziridin-1-yl)-2,4-dinitrobenzamide (CB 1954) by human NAD(P)H quinone oxidoreductase 2: a novel co-substrate-mediated antitumor prodrug therapy.
    Knox RJ; Jenkins TC; Hobbs SM; Chen S; Melton RG; Burke PJ
    Cancer Res; 2000 Aug; 60(15):4179-86. PubMed ID: 10945627
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Caffeine, aminoimidazolecarboxamide and dicoumarol, inhibitors of NAD(P)H dehydrogenase (quinone) (DT diaphorase), prevent both the cytotoxicity and DNA interstrand crosslinking produced by 5-(aziridin-1-yl)-2,4-dinitrobenzamide (CB 1954) in Walker cells.
    Roberts JJ; Marchbank T; Kotsaki-Kovatsi VP; Boland MP; Friedlos F; Knox RJ
    Biochem Pharmacol; 1989 Nov; 38(22):4137-43. PubMed ID: 2480794
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Catalytic properties of NAD(P)H:quinone oxidoreductase-2 (NQO2), a dihydronicotinamide riboside dependent oxidoreductase.
    Wu K; Knox R; Sun XZ; Joseph P; Jaiswal AK; Zhang D; Deng PS; Chen S
    Arch Biochem Biophys; 1997 Nov; 347(2):221-8. PubMed ID: 9367528
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of novel reduced pyridinium derivatives as synthetic co-factors for the enzyme DT diaphorase (NAD(P)H dehydrogenase (quinone), EC 1.6.99.2).
    Friedlos F; Jarman M; Davies LC; Boland MP; Knox RJ
    Biochem Pharmacol; 1992 Jul; 44(1):25-31. PubMed ID: 1385952
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The differences in kinetics of rat and human DT diaphorase result in a differential sensitivity of derived cell lines to CB 1954 (5-(aziridin-1-yl)-2,4-dinitrobenzamide).
    Boland MP; Knox RJ; Roberts JJ
    Biochem Pharmacol; 1991 Mar 15-Apr 1; 41(6-7):867-75. PubMed ID: 1901207
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A new cytotoxic, DNA interstrand crosslinking agent, 5-(aziridin-1-yl)-4-hydroxylamino-2-nitrobenzamide, is formed from 5-(aziridin-1-yl)-2,4-dinitrobenzamide (CB 1954) by a nitroreductase enzyme in Walker carcinoma cells.
    Knox RJ; Friedlos F; Jarman M; Roberts JJ
    Biochem Pharmacol; 1988 Dec; 37(24):4661-9. PubMed ID: 3202902
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of redox cycling and activation by DT-diaphorase in the cytotoxicity of 5-(aziridin-1-yl)-2,4-dinitrobenzamide (CB-1954) and its analogs.
    Miŝkiniene V; Sergediene E; Nemeikaite A; Segura-Aguilar J; Cenas N
    Cancer Lett; 1999 Nov; 146(2):217-22. PubMed ID: 10656629
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The nitroreductase enzyme in Walker cells that activates 5-(aziridin-1-yl)-2,4-dinitrobenzamide (CB 1954) to 5-(aziridin-1-yl)-4-hydroxylamino-2-nitrobenzamide is a form of NAD(P)H dehydrogenase (quinone) (EC 1.6.99.2).
    Knox RJ; Boland MP; Friedlos F; Coles B; Southan C; Roberts JJ
    Biochem Pharmacol; 1988 Dec; 37(24):4671-7. PubMed ID: 3144286
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metabolism of NAD(P)H by blood components. Relevance to bioreductively activated prodrugs in a targeted enzyme therapy system.
    Friedlos F; Knox RJ
    Biochem Pharmacol; 1992 Aug; 44(4):631-5. PubMed ID: 1387314
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Demonstration of the activation of prodrug CB 1954 using human DT-diaphorase mutant Q104Y-transfected MDA-MB-231 cells and mouse xenograft model.
    Wu K; Eng E; Knox R; Chen S
    Arch Biochem Biophys; 2001 Jan; 385(1):203-8. PubMed ID: 11361019
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The bioactivation of CB 1954 and its use as a prodrug in antibody-directed enzyme prodrug therapy (ADEPT).
    Knox RJ; Friedlos F; Boland MP
    Cancer Metastasis Rev; 1993 Jun; 12(2):195-212. PubMed ID: 8375021
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bioactivation of CB 1954: reaction of the active 4-hydroxylamino derivative with thioesters to form the ultimate DNA-DNA interstrand crosslinking species.
    Knox RJ; Friedlos F; Marchbank T; Roberts JJ
    Biochem Pharmacol; 1991 Oct; 42(9):1691-7. PubMed ID: 1930294
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Virtual cofactors for an Escherichia coli nitroreductase enzyme: relevance to reductively activated prodrugs in antibody directed enzyme prodrug therapy (ADEPT).
    Knox RJ; Friedlos F; Jarman M; Davies LC; Goddard P; Anlezark GM; Melton RG; Sherwood RF
    Biochem Pharmacol; 1995 May; 49(11):1641-7. PubMed ID: 7786305
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metabolism of diaziquone by NAD(P)H:(quinone acceptor) oxidoreductase (DT-diaphorase): role in diaziquone-induced DNA damage and cytotoxicity in human colon carcinoma cells.
    Siegel D; Gibson NW; Preusch PC; Ross D
    Cancer Res; 1990 Nov; 50(22):7293-300. PubMed ID: 2121335
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular characterization of binding of substrates and inhibitors to DT-diaphorase: combined approach involving site-directed mutagenesis, inhibitor-binding analysis, and computer modeling.
    Chen S; Wu K; Zhang D; Sherman M; Knox R; Yang CS
    Mol Pharmacol; 1999 Aug; 56(2):272-8. PubMed ID: 10419545
    [TBL] [Abstract][Full Text] [Related]  

  • 17. DT-diaphorase protects cells from the hypoxic cytotoxicity of indoloquinone EO9.
    Plumb JA; Gerritsen M; Workman P
    Br J Cancer; 1994 Dec; 70(6):1136-43. PubMed ID: 7526885
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Catalytic properties of NAD(P)H:quinone acceptor oxidoreductase: study involving mouse, rat, human, and mouse-rat chimeric enzymes.
    Chen S; Knox R; Lewis AD; Friedlos F; Workman P; Deng PS; Fung M; Ebenstein D; Wu K; Tsai TM
    Mol Pharmacol; 1995 May; 47(5):934-9. PubMed ID: 7746280
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The bioactivation of 5-(aziridin-1-yl)-2,4-dinitrobenzamide (CB1954)--II. A comparison of an Escherichia coli nitroreductase and Walker DT diaphorase.
    Knox RJ; Friedlos F; Sherwood RF; Melton RG; Anlezark GM
    Biochem Pharmacol; 1992 Dec; 44(12):2297-301. PubMed ID: 1472095
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CB 1954: from the Walker tumor to NQO2 and VDEPT.
    Knox RJ; Burke PJ; Chen S; Kerr DJ
    Curr Pharm Des; 2003; 9(26):2091-104. PubMed ID: 14529407
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.